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Immunization of certain strains of rats or mice with native type II collagen in 
incomplete Freund's adjuvant  induces an  inflammatory polyarthritis, collagen- 
induced arthritis (CIA) 1 (1,  2).  Although the pathogenesis of this experimental 
disease is still incompletely understood, antibodies directed against epitopes on 
the collagen molecules in articular cartilage appear to play an important role (3- 
6).  A  similar  but  clinically  and  histologically  distinct joint  disease,  adjuvant 
arthritis (AA), is produced in rats by intradermal injection of complete Freund's 
adjuvant (CFA) or other materials with immunoadjuvant activities similar to that 
of CFA (7-9). We (10,  1 1) and others (12,  13) have recently provided evidence 
from adoptive transfer studies that AA is primarily mediated by cellular immune 
mechanisms. 
In  this  paper  we  report that  the  pathogenetic  mechanisms  of AA  and  CIA 
synergize to produce an  extraordinarily severe arthritic process.  This synergy 
provides evidence  that  AA  and  CIA  are  induced  by  fundamentally  different 
mechanisms;  furthermore,  it provides a  model for studying the interaction of 
humoral and cellular immune effector mechanisms in the pathogenesis of joint 
inflammation. 
Materials and Methods 
Animals.  Outbred Wistar rats from Royalhart Lab Animals, New Hampton, NY, were 
used for the  production of antibody. In all other experiments, specific pathogen-free 
inbred LEW]SsN rats, obtained through the Frederick Cancer Research Center, Freder- 
ick, MD, from Charles River Breeding Laboratories, Inc., Wilmington, MA, were used. 
Collagen and Antibody Preparations.  Native bovine type collagen (CII) was  purified 
from bovine nasal septum (1,4). Affinity-purified  anticollagen IgG (anti-CII) was prepared 
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as previously described in detail (4). Affinity-purified anti-ovalbumin (anti-OVA) antibody 
was prepared in a  similar manner from the pooled serum of rats immunized with OVA. 
Antibody concentrations  were measured by enzyme-linked immunoassay, as previously 
described (4), and adjusted to 6 mg/ml. Normal rat gamma globulin (NRGG) was prepared 
from normal rat serum by the method of Stuart et al. (3). 
Induction of  Arthritis.  AA was induced with 100% incidence in 5-10-wk-oid LEW rats 
of either  sex by a  single  intradermal  injection  into the  tail,  of a  suspension  of 0.6  mg 
Mycobacterium butyricum (Difco Laboratories, Inc., Detroit, MI) in oil (CFA), prepared as 
previously described (11).  CIA was induced with >90%  incidence by a  modification of 
the method of Stuart et al. (3); in brief, rats were given two intradermal injections,  1 wk 
apart, of 0.2 mg CII in incomplete Freund's adjuvant into the tail. 
Cell Cultures.  Lymph node (LN) and spleen cell suspensions, prepared as previously 
described (11), were cultured  1-3 d  (usually 2 d) in Dulbecco's modified Eagle's medium 
(M. A. Bioproducts, Walkersville,  MD) containing 4.5 g/liter of glucose,  10 mM Hepes, 
50  #g/mi  penicillin,  50  /~g/ml  amikacin  (Bristol  Laboratories  Div.,  Bristol-Myers  Co., 
Syracuse,  NY),  5%  horse  serum  (K.C.  Biological,  Inc.,  Lenexa,  KA),  and  2  ~g/ml 
concanavalin A  (Con A) (Miles-Yeda,  Rehovot,  Israel),  at  2  x  10  ~ celis/ml  in  150-cm  ~ 
flasks,  at  37°C  in  a  humidified  95%  air/5%  COs  atmosphere.  In  some  experiments, 
phytohemagglutinin (PHA-M; Difco Laboratories, Inc.),  1% vol/vol, was substituted  for 
Con A in cultures of AA lymphoid cells. 
Injections.  6-10-wk-old LEW/SsN rats of either sex were given intravenous injections 
of anti-CII or control antibodies  in phosphate-buffered  saline and/or  lymphoid cells in 
serum-free culture medium. Cells irradiated just before transfer were exposed to either 
1,000 or 1,500 rad from a  ~S~Cs source (J. L. Shepherd & Associates, Glendale, CA). 
Evaluation of Arthritis.  After injection  of cells and/or  antibody,  rats  were clinically 
evaluated three to six times per week until the end of the experiment.  In initial experi- 
ments, it became clear that diffuse, symmetric involvement of every joint of the four paws 
was a major effect of the synergistic arthritis. To quantitate this arthritis most accurately, 
a scoring system was devised in which each joint was separately evaluated for swelling and 
erythema;  this  system  is  outlined  in Table  I.  The  knee  was excluded  because  neither 
swelling nor erythema of the knee could be reliably quantitated by physical examination. 
TABLE  I 
Scoring System  for Clinical Evaluation of Arthritis 
Part 
Joint score range 
Swelling*  Erythema* 
Forepaw 
Wrist  0-4  0-2 
Hand/MCP joints  0-8  0-4 
Digits  0-8  0-4 
Hindpaw 
Ankle  0-8  0-4 
Mid-tarsals  0-8  0-4 
MTP joints  0-10  0-2 
Digits  0-10  0-2 
Maximum scores: forepaw,  30; hindpaw,  48; rat,  156. MCP, metacar- 
pophalangeal;  MTP, metatarsophalangeal. 
* The wrists,  ankles,  and mid-tarsals  were each considered as separate 
right  and  left  compartments,  each  compartment  with  half the  total 
maximum possible score. Each MCP and MTPjoint and each digit were 
given a score of 0-2. The first forepaw digits were not scored separately, 
but were considered part of the wrist. 
* Erythema was scored in each region as follows: 4, deep violaceous; 3, 
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Examinations  were  carried out  under constant  fluorescent  lighting  by  either  of two 
observers (JDT or SLL), with interobserver  variation of the joint scores of <15%. 
Radiography.  Radiographs  were  prepared as previously described  (10), and scored 
blindly by one observer (MLM); abnormalities were graded as follows:  periosteai reaction, 
0-3 (none, slight, moderate, marked); erosions, 0-3 (none, few, many small, many large); 
joint space narrowing,  0-3 (none, minimal, moderate, marked); joint space destruction, 
0-3 (none, minimal, extensive, ankylosis). 
Histopathology.  Tissues were fixed in  10%  neutral-buffered formalin.  Larynges and 
ears were embedded in paraffin.  As previously described  (4), paws were decalcified in 
EDTA, then embedded in methacrylate and sectioned at 3-4/~m; sections were stained 
with a modified Giemsa (American Histolabs, Rockviile, MD). 
Immunofluorescence.  Frozen  sections were prepared from hindpaws and studied for 
immunoglobulin and C3 deposition, as previously described in detail (4). Formal evaluation 
of immunofluorescence  and  histopathology  was  carried  out  blindly  by  one  observer 
(RAM). 
Statistics.  Paired  means  were compared by Student's t test.  Three or more group 
means were compared by one-way analysis of variance, with an assumed significance level 
ofP < 0.05 (14). 
Results 
Synergy Between Passively Administered Cells and Antibody.  (Tables II-IV, and 
Figs.  1 and 2). Synergy between AA and CIA was observed when normal LEW 
rats were intravenously given varying amounts of anti-CII, followed within 1 d 
by  varying  numbers  of adjuvant-sensitized,  Con  A-stimulated  (AA/Con  A) 
syngeneic LN or spleen cells.  The arthritis induced by anti-CII and AA/Con A 
cells appeared 3-6 d after cell transfer. In most instances, every  joint of the four 
paws  showed  severe  swelling and  erythema (Fig.  1).  The arthritis peaked  in 
severity within 2 wk of cell administration; after 3 wk, the erythema generally 
began to subside; residual deformity, including widespread joint ankylosis, was 
the rule after 6 wk or more. In rats not given anti-CII, AA/Con A LN or spleen 
cells induced a  moderately severe,  asymmetric arthritis  that  tended to  affect 
primarily the ankles, midtarsal regions, and,  to a  lesser extent, the wrists;  the 
small joints of the hind- and forepaws were much less  often involved (Fig.  1; 
Table II, group E, and Table III, group L), as previously described (10,  11). 
In rats given both AA/Con A  spleen cells and anti-CII, increasingly severe 
arthritis resulted with coadministration of increasing doses of AA/Con A lymph- 
oid cells and increasing doses of anti-CII (Fig. 2; Table II, groups C and D; and 
data not shown). In contrast, in rats given AA/Con A LN cells (Table III, group 
J) no significant differences in the severity of the arthritis resulted from doses of 
anti-CII of 6,  12, or 24 mg (separate peak joint scores, 130 +  15,  124 __+ 21, and 
150 _+ 8, respectively; P >  0.05). This may have been due to the generally larger 
doses of LN cells given. Some synergy was also observed when large numbers of 
uncultured  LN  or  spleen  cells  were  transferred directly from AA  donors  to 
recipients simultaneously given anti-CII (Table II, groups H  and I; Table III, 
groups M and N), although the arthritis was significantly less severe than that of 
rats receiving anti-CII and AA/Con A cells. 
Given without cells,  24  mg of anti-CII reproducibly induced within 24  h  a 
mild, symmetrical hindfoot arthritis that rarely lasted >1  wk (Table II, group 
A).  A  dose of 12  mg of anti-CII induced a  similar arthritis in some recipients 
and no detectable arthritis in others. As previously observed (4), doses of 3 or 6 TAUROG  ET  AL.  965 
FIGURE  1.  Forepaws of representative rats receiving 1 X 10  s AA/Con A LN cells (a), or the 
same dose of cells together with 12 mg anti-CII (b), photographed 13 d after passive transfer. 
In a, there was mild swelling and erythema of the wrist and ulnar  three MCP joints.  In b, 
there was diffuse soft tissue swelling and intense erythema of the entire paw, with prominent 
synovitis of all the metacarpophalangeal  and interphalangeal joints.  This degree of diffuse 
swelling and erythema, in both hind and forepaws, is typical of the synergy between AA and 
CIA. 
mg anti-CII caused  no  detectable  arthritis  (Table  II, group  B).  The  ability  of 
administered anti-CII to synergize with AA/Con  A  cells persisted for at least 4 
wk, the longest time interval examined (Table III, group K). 
The  synergy  between  anti-CII  and  AA  lymphoid  cells  in  the  induction  of 
arthritis showed specificity. No synergy was seen when either NRGG in doses up 
to  100  mg or  24  mg of affinity-purified anti-OVA  was given with  AA/Con  A 
cells (Table IV, groups O-Q). Con A-stimulated lymphoid cells from LEW rats 
with  CIA showed  neither  arthritogenicity  when  given alone nor synergy when 
given with anti-CII, nor was there evidence of synergy between anti-CII and Con 
A-stimulated cells from normal LEW rats (Table IV, groups T-W). 
By  far  the  most  severe  arthritis  and  most  striking  synergy  were  seen  in 
recipients of anti-CII and AA LN or spleen cells cultured with Con A; AA cells 966  SYNERGY  BETWEEN  ADJUVANT  AND  COLLAGEN  ARTHRITIS 
TABLE  II 
Synergy Between Anti-CII and AA Spleen Cells in the Induction of Passively Transferred 
Arthritis 
Anti-CII  Peak joint score 
Cell dose  Arthritis 
Group  AA spleen cells given  (× I 0 -T)  dose  incidence  Mean ± 
(mg)  SD*  Range 
mg 
A  None  --  12-24  10/13  7 ±  4  2-16 
B  None  --  3-6  0/5 
C  Con A-stimulated  1.5-5.4  12-24  22/22  140 ±  16  99-156 
D  Con A-stimulated  1.5-5.4  6  10/10  107 ±  22  70-144 
E  Con A-stimulated  2.4-6.6  0  24/26  23 ±  12  7-44 
F  Con A-stimulated, irradiated*  4.0  12  2/3  8 -  3  5-10 
G  Con A-stimulated, irradiated  4.0  0  0/2 
H  Not cultured  20-34  6  6/7  19 ±  5  13-25 
I  Not cultured  20-34  0  0/6 
Tables II-IV summarize passive transfer experiments using 19 separate groups of cell donors and 
four separate preparations of anti-CII. AA cells were harvested 10-12 d after inoculation of donors 
with CFA. Cells were given  1 min  to  1 d  after antibody;  viable cells were counted just  before 
transfer. 
* Rats that failed to develop arthritis (i.e., scores of 0) were excluded from this calculation. Significant 
differences (P  <  0.05  by  analysis  of variance)  are  represented  by  the  symbol  >,  insignificant 
differences by the symbol --, as follows: group C >  D >  E -- H >  F =  A >  B =  G =  1. 
* 1,500 rad irradiation. 
TABLE  III 
Synergy Between Anti-CII and AA LN Cells in the Induction of Passively Transferred Arthritis 
Cell dose  Anti-CII  Arthritis  Peak joint score 
Group  AA LN cells given  (× 10 -7)  dose (mg)  incidence  Mean ±  SD*  Range 
mg 
J  Con A-stimulated,  4.5-13.0  6-24  20/20  132 ±  19  90-156 
K*  12.6  12  3/3  85 ±  26  74-107 
L  6.2-12.2  0  13/15  22 ±  14  3-42 
M  Not cultured  27-30  6  2/3  60 +  0  60 
N  27-30  0  2/2  20 __. 12  9-32 
Procedures were as described in the legend to Table II, except for group K, as noted below. 
* GroupJ >  K> M >  L =  N. 
* AA/Con A LN cells were given 4 wk after anti-CII. 
cultured  with PHA-M  were  much  less effective in synergizing  with anti-CII  than 
AA  cells cultured  with Con  A  (Table  IV, groups  R  and  S, and  data  not shown). 
Similar  levels  of  [3H]thymidine  incorporation  were  stimulated  by  Con  A  and 
PHA-M  in  AA  LN  and  spleen  cells (data  not  shown).  Irradiation  of AA/Con  A 
cells abrogated  their  ability  to  synergize  with  anti-CII  (Table  II,  groups  F  and 
G; see also Fig. 4). 
Synergy Between Active and Passive Disease.  To  determine  if the  synergy  be- 
tween  anticollagen  antibody  and  AA  cells  could  also  be  observed  in  actively 140 
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FIGURE 2.  Early course of arthritis passively transferred by AA/Con A  spleen cells in the 
presence or absence of coadministered  anti-CII. Data are taken from groups C, D, and E listed 
in Table II; all rats for which complete time course data were obtained are included. The 
three groups were significantly different at all  time points past day 5 (P <  0.05).  A  similar 
time course was observed in the respective recipients of AA/Con A LN cells with and without 
anti-CII, except that there were no significant differences between the two LN cell recipient 
groups receiving 6  and  12  mg  of anti-CII  (see  text).  Bars  represent +1  SD  in  this  and 
subsequent figures. (O) Anti-CII, 12 mg, 2.4-5.4 ×  107 cells (n =  14); (A) anti-CII, 6 rag, 2.4- 
5.4 ×  107 cells (n =  10); (0) no antibody, 2.4-6.6 x  107 cells (n =  20). 
TABLE  IV 
Specificity of Both AA/Con A Cells and Anticollagen Antibody in the Synergistic Induction of 
Passively Transferred  Arthritis 
Arthri-  Peak joint score 
Cell dose  Antibody  tis inci-  Group  Cells given *  (x 10  -7)  Antibody  dose  Mean + 
dence  SD*  Range 
mg 
O  AA spleen/Con A  5.0  Anti-OVA  24  2/2  5 -4- 3  2-8 
P  AA LN/Con A  11.0-12.0  Anti-OVA  24  3/4  5  5-6 
Q  AA LN/Con A  10.0-13.0  NRGG  12-100  3/6  7 _  1  6-8 
R  AA LN/PHA  7.8-9.0  Anti-CII  6  3/4  27 __. 19  5-39 
S  AA LN/PHA  7.8-9.0  None  --  2/3  5 _  2  3-7 
T  CIA spleen/Con A  4.6-5.5  Anti-CII  12  4/5  9 +  8  3-16 
U  CIA spleen/Con A  4.6  None  --  0/3 
V  CIA LN/Con A  7.5  Anti-CII  12  0/5 
W  Normal LN/Con A  8.6-12  Anti-CII  12  I/2  8  8 
Procedures were as described in the legend to Table If, except as described below. 
* CIA cells were harvested 13 d after primary immunization of donors with CII, by which time all 
donors had developed arthritis. 
t Groups R, U, and V are significantly different from the other six groups. 968  SYNERGY  BETWEEN  ADJUVANT  AND  COLLAGEN  ARTHRITIS 
induced arthritis,  rats with actively induced AA or CIA were reciprocally given 
either anti-CII or AA/Con A spleen cells. Within 2 d of administration of 12 mg 
of anti-CII to rats with established AA, a marked, sustained increase in arthritic 
severity occurred (Fig. 3). Normal rat gamma globulin had no significant effect. 
Similarly, administration of 5 X 107 AA/Con A spleen cells to rats with established 
CIA produced a  marked,  sustained increase in arthritic  severity (Fig.  4), while 
irradiated AA/Con A spleen cells from the same cultures had no effect. Admin- 
istration  of 5 x  107 Con A-stimulated  AA spleen cells to rats with established, 
actively induced AA had no effect on the severity or course of the disease (data 
not shown). 
Synergy Between the Two Active Diseases.  To determine if synergy could occur 
between actively induced AA and CIA, conventional doses of CFA and CII were 
separately administered  to groups of rats,  either simultaneously or 2 wk apart. 
As shown in Fig. 5, the arthritic  severity of rats simultaneously given CFA and 
CII exceeded the sum of the arthritic scores of rats given each agent alone. Rats 
that received the two agents 2 wk apart showed biphasic arthritic responses, with 
arthritic  scores that were essentially additive when compared with the scores of 
rats  receiving each agent alone.  Rats receiving both CFA and  CII consistently 
showed diffuse, symmetric involvement of the small joints of the forepaws that 
was not seen in either of the two control groups. 
Radiographic Evaluation  of Passively Transferred Arthritis.  Rats given arthri- 
togenic  doses of anti-CII  alone  showed  no  radiographic  changes  (results  not 
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FIGURE 3.  Synergistic effect of anticollagen antibody on actively induced AA.  10 rats were 
injected with CFA on day -13; on day 0, all rats had arthritis and were randomly selected to 
receive intravenously either  12 mg of anti-CII (four rats),  12  mg of NRGG (four rats), or 
nothing (two rats). One rat in the group receiving anti-CII died after anesthesia for roentgen- 
ography on day 13. The anti-CII-treated group was significantly different from the other two 
groups at each point past day 2 (P < 0.05). Similar results were obtained in a second experiment. 
(O) Anti-CII, 12 rag; (O) NRGG,  12 rag; (,) control. TAUROG  ET  AL.  969 
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FIGURE 4.  Synergistic effect of AA/Con A spleen cells on actively induced CIA. 10 rats were 
given 0.2 mg CII in incomplete Freund's  adjuvant on day -34 and day -27; all rats developed 
arthritis. On day 0, rats were randomly selected to receive intravenously 5 X 107 AA]Con A 
spleen cells nonirradiated (three rats) or irradiated at 1,000 rad just before transfer (three 
rats), or nothing (four rats). The  AA/Con A spleen cell-treated  group was significantly 
different from the other two groups at each point past day 2. Similar results were obtained in 
a second experiment, in which AA/Con A spleen cells were transferred on day_ 0 to rats 
immunized with CII on day -13 and day -6. (O) AA/Con A spleen cells, 5 x  107; (A) AA/ 
Con A spleen cells, 5 x 107, 1,000 rad; (O) control. 
shown). In contrast, radiographic abnormalities developed in animals receiving 
AA/Con A  cells alone or in conjunction with anti-CII. These results are  sum- 
marized in Table V and illustrated in Figs. 6 and 7. 
In rats given AA/Con A cells alone, abnormalities consisted of asymmetric soft 
tissue swelling and small erosions, periosteal thickening, and minimal joint space 
narrowing, predominantly localized to the proximal areas of the paws (Figs. 6 a, 
7a).  At  3  mo,  these  rats  had developed definite joint space  narrowing of the 
intertarsal joints (Fig. 6 b); forepaw changes were not apparent (Fig. 7 b). 
In contrast to the mild changes induced by AA/Con A  cells alone,  marked 
changes were present in the recipients of both AA/Con A cells and anti-CII. At 
19 d, changes in these rats consisted of diffuse soft tissue swelling that included 
the digits, diffuse demineralization of bone, marked periosteal thickening, and 
cystic enlargement of bone. Extensive erosions produced narrowing or pseudo- 
widening of all joint  spaces  (Figs.  6c,  7c).  By  7  wk,  soft tissue  swelling had 
diminished, bones were denser, and bony enlargement was more pronounced. 
Joint space destruction, pseudo-widening, ankylosis, and subluxation were wide- 
spread.  These changes persisted  upon examination at  3  mo (Figs.  6d,  7d).  In 
rats given both CFA and CII (Fig.  5), radiographic changes were qualitatively 
similar to those shown in Figs. 6 c, 6 d, 7 c, and 7 d (data not shown). 
Immunofluorescence.  Rats injected with 12 mg anti-CII, with or without AA/ 
Con A  cells, and sacrificed on the second or fourth day after injection, showed 
bright linear fluorescence for IgG along the articular surfaces of their intertarsal 
joints; slight but definite fluorescence for C3 was also present in several of these 
rats.  These  findings were  very similar  to  those  previously reported  (4).  Rats 970 
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FIGURE 5.  Synergy between actively induced AA and actively induced CIA. Data have been 
pooled from a  total of three experiments. In each experiment, rats were divided into five 
groups and given: CFA alone, CI1 in IFA alone, CFA and CII together, CFA followed 2 wk 
later by CII, and CII followed 2 wk later by CFA. Rats given CII were boosted 1 wk after the 
first injection, as described in Materials and Methods. Each point represents the composite 
mean +  SD arthritis score for all arthritic animals in the indicated treatment group during the 
time period indicated. 2 of 14 rats given CII alone failed to develop arthritis and have been 
excluded from the computations; all rats in all other groups developed  arthritis. (*) Significantly 
different from both control groups at this and all subsequent time points. (11) CFA alone (n --- 
13); (A) CII alone (n =  12); (©) CFA +  CII on day 0 (n =  14); (A) CFA on day 0, CII on day 
14 (n -  14); (0) CII on day 0, CFA on day 14 (n =  14). 
TABLE  V 
Radiographic Evidence for Synergy between AA Lymphoid Cells and Anti-CII Antibody 
Group  Radiographs 
Days after cell transfer 
19-21  50  97 
A (AA cells alone)  Forepaws  2.0 +  2.7  1.4 --+ 2.3  0 --+ 0 
Hindpaws  3.3 +_ 2.5  8.4 +  8.3  9.4 +  10.4 
Total  5.3 +  4 (12)  9.9 +  8.3 (7)  9.4 +  10.4 (7) 
B (AA ceils + anti-CII)  Forepaws  18.0 ___ 6.9  17.9 _+ 6.9  16.6 +  8.4 
Hindpaws  21.5 +  3.1  21.5 _  3.4  21.6 _  3.2 
Total  39.5 --- 8.5 (16)  39.4 _+ 8.6 (10)  38.2 +  10.6 (9) 
All rats were given either 3-4 x  107 AA/Con A spleen cells or 1 x  l0  s AA/Con A LN cells; rats in 
group B also received 6-24 mg anti-CII. Radiographs taken at the time points indicated were scored 
blindly as described in Materials and Methods. Data represent mean +  SD of the scores for all rats 
in each group. Numbers in parentheses represent the number of rats radiographed in each group at 
each time point. All paired comparisons between groups A and B at each time point are significant 
at P <  0.001. 
receiving AA/Con A  cells alone had no detectable IgG or C3  binding to joint 
structures. 
Histopathology.  Intertarsal joints from rats given anti-CII alone, AA/Con A 
cells alone, or both agents together, were examined serially (Fig.  8).  By day 2 
after  the administration  of AA/Con  A  cells plus anti-CII,  pathologic changes TAUROG  ET  AL.  911 
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FIGURE 7.  Serial radiographic appearance  of the  forepaws  of the two  representative rats 
shown in Fig. 6. See Fig. 6 legend for identification of panels (a-d). (a) The only abnormality 
was soft tissue swelling of the left wrist. (b) There was slight widening of the distal radius due 
to periosteal proliferation; the distal third and fourth metacarpals were slightly enlarged; the 
distal carpal row on the right had fused. (c) The soft tissues were diffusely swollen. The shafts 
of the ulna, radius, distal metacarpals and proximal phalanges showed extensive bony enlarge- 
ment.  Large erosions of the  carpal and  carpometacarpal joints  result  in  shortening of the 
carpal space. There was extensive destruction of the metacarpophalangeal (MCP) and proximal 
interphalangeal  (PIP)joints.  (d)  The proximal  metacarpals  had  undergone  bony ankylosis. 
The proximal phalanges remained enlarged and some erosions persisted in the MCP and PIP 
joints.  The  carpal  bones  had  almost  completely dissolved,  and  bony  lysis had  also  caused 
shortening of the distal ulna and radius. 
FIGURE 8.  Effects of 7 X 107 AA/Con A LN cells plus 12 mg anti-CII antibody, days 4-10 
after antibody and cell administrations (a-c); effects of 4 x  l0  T AA/Con A spleen cells with or 
without 6 mg anti-CII, 21  d after antibody and cell administration (d-f).  (a) Day 4, cells plus 
antibody. Neutrophils were closely applied to the articular surface of the cartilage, and lay in 
superficial  erosions  (arrow).  A  mantle  of macrophages  (arrowheads)  covered  the  layer of 
neutrophils.  Giemsa,  x  25.  (b)  Day  6,  cells plus antibody.  There  was  extensive erosion of 
articular cartilage (C), with layering of neutrophils on the articular surface and exudate within 
the joint space. Osteoclasts (arrowheads) are associated with resorption of subchondral bone 
at the margin of the articular cartilage. Giemsa, x  10. (c) Day  10, cells plus antibody. There 
was extensive destruction of articular cartilage (C), and of subchondral bone. Giemsa, x  6.3. 
(d)  Day 21, cells plus antibody. There was extensive destruction of articular cartilage (C) and 
subchondral bone, with the formation of partial synchondrosis (SC).  Little inflammation was 
present, associated with areas of active bone resorption (arrowheads indicate osteoclasts). All 
intertarsal joints in this group were similarly involved. Giemsa, x  10. (e)  Day 21, cells plus 
antibody. Osteoneogenesis and bone resorption were marked and extensive. CB, original bone 
cortex  being  eroded  by  osteoclasts  (closed  arrowheads).  N,  new  bone;  osteoblasts  (open 
arrowhead) surround the new matrix. Giemsa, x  10. (f) Day 21, cells alone. Osteoneogenesis 
was  present  but  less  marked  than  in  e.  CB,  original  bone  cortex;  arrowhead,  osteoblasts. 
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consisted of infiltration of a  few neutrophils into mildly edematous synovium. 
By day 4, destructive lesions were evident in articular cartilage (Fig. 8a). By day 
6,  there was  frank exudation into  the joint  space,  more extensive erosion of 
articular cartilage by neutrophils,  and marginal  erosion of subchondral bone 
(Fig. 8 b); these destructive changes were more extensive on day 10 (Fig. 8 c). By 
day  21,  the  acute,  exudative  changes  had  subsided;  residual  destruction  of 
cartilage and cortical bone, and florid osteoneogenesis, were characteristic find- 
ings (Fig. 8, d and e). 
Rats receiving AA/Con A  cells alone had minimal inflammatory changes by 
day 4; these had progressed only slightly by day 10.  By day 21, mild osteoneo- 
genesis was apparent (Fig.  8f).  Rats receiving anti-CII alone showed minimal 
inflammatory changes on day 4 only. No pathologic changes were found in the 
larynges or ears of any rat, whether treated with anti-CII, AA/Con A  cells, or 
both. 
Discussion 
Although  adjuvant  arthritis  has  been  extensively studied  since  it  was  first 
observed three decades ago (7),  no specific inciting or target antigen has been 
convincingly implicated  in  the  pathogenesis  of the  disease.  Nonetheless,  the 
evidence that a cell-mediated immune response is primarily responsible for AA 
is quite strong, and several investigators have demonstrated that lymphoid cells 
derived from adjuvant-treated rats can adoptively transfer inflammatory arthritis 
(10-13,  15-17).  In  most  of these  systems,  some  manipulation  of either  the 
transferred cells or the recipients or both has been necessary to obtain reproduc- 
ible transfer of arthritis.  Such manipulation has  included coadministration of 
transferred cells with a subarthritogenic dose of adjuvant (17), treatment of the 
transferred cells with Con A in vitro (10,  1 1), transfer of mycobacterial antigen- 
specific T  cell lines (12,  13), and immunosuppression of the recipients (10,  12, 
13).  In all of these systems, the passively transferred arthritis generally is  less 
severe and involves fewer  joints than in conventional, actively induced AA. 
One interpretation of these results posits that the manipulations are necessary 
to  overcome the resistance of the normal  host synovium to  the induction of 
inflammation by the transferred cells,  in  contrast to  actively induced AA,  in 
which the pro-inflammatory adjuvant has been shown to  disseminate to joint 
tissues  (18).  We  reasoned  that,  if local  synovial  alterations  promote  arthritis 
induced by AA lymphoid cells, then the administration of antibody to type II 
collagen, which has been shown to bind rapidly in vivo wherever there is articular 
cartilage (19) and to produce transient inflammation in large joints (3-5), should 
augment the severity of the arthritis passively transferred with AA cells. 
This prediction was borne out in the experiments described in this paper; in 
normal  rats  given  anti-CII  and  AA  lymphoid  cells,  we  observed  a  striking, 
synergistic arthritis as a  specific and dose-dependent effect of the two compo- 
nents. Compared with the arthritis induced by transfer of either AA cells alone 
or anti-CII  alone,  this  synergy was  manifested clinically by earlier and  more 
abrupt onset of arthritis, and by more prominent, diffuse, and symmetric swelling 
and erythema; histological manifestations were an earlier, more diffuse, and far 
more phlogistic and erosive appearance; and radiographic manifestations were TAUROG  ET  AL.  975 
more diffuse and intensive joint destruction and reactive osteoneogenesis. Similar 
results  were seen  when  rats  with active AA or CIA were given the  reciprocal 
passive  component,  and  when  both  active  diseases were induced  in  the  same 
hosts. 
From these data we may draw the following conclusions: (a) antibody to type 
II  collagen,  bound  to articular  cartilage,  can  serve as a  latent  arthritogen  in 
virtually  any  synovial joint  by interacting  with  specifically stimulated  cellular 
components; (b) lymphoid cells from AA rats have a substantially greater capacity 
than do lymphoid cells from CIA rats to induce severe, destructive arthritis;  (c) 
AA and CIA are pathogenetically distinct diseases. 
Several possible mechanisms can be envisioned for the observed synergy. The 
antibody  on  the  articular  surface  probably  serves  to  focus within  the joint  a 
variety of cells bearing  Fc receptors.  Complement  fixation  by the  bound  IgG 
could  be  expected  to  increase  synovial  vascular  permeability  and  neutrophil 
migration into the joint; this in turn would be expected to render the joint more 
susceptible  to  the  entry  and  pro-inflammatory  effects  of  cytokine-secreting 
lymphoid cells. 
The passive transfer experiments presented here did not address the relative 
effector roles of the administered cells and of recruited host cells; although  the 
vast majority of the  administered  cells were lymphocytes or lymphoblasts,  the 
predominant  cells in  the  early  lesions  of the  synergistic  passive arthritis  were 
neutrophils and macrophages.  Indeed, we have only indirect evidence that  the 
administered  AA cell population contained effector cells that themselves traffic 
to joints.  We have observed that  AA/Con A  LN or spleen cells induce passive 
arthritis  equally well in  intact,  splenectomized,  or sham-splenectomized  recipi- 
ents; however, our efforts by a variety of methods to directly demonstrate specific 
trafficking  of AA/Con  A  lymphoid cells to joints  have all  failed (unpublished 
results).  At  present,  we  speculate  that  relatively  few  AA  effector  cells  are 
necessary for induction of arthritis in a particular joint, especially in the case of 
synergy with anti-CII. 
Con A-stimulated cells from rats with CIA were found not to synergize with 
anti-CII,  nor  were  they arthritogenic  when  given  alone  (Table  IV).  In  other 
experiments,  we obtained the same negative results with large numbers (>5  × 
108) of CIA LN and spleen cells transferred directly, and with CIA cells cultured 
in  vitro with type II collagen (unpublished results).  These results conflict with 
those of Trentham  et al. (20), who observed that large numbers of CIA LN and 
spleen cells could transfer arthritis  in  LEW rats.  While the explanation  for this 
difference is not apparent,  there is substantial evidence for the participation  of 
cell-mediated immune  mechanisms  in  the pathogenesis of collagen-induced ar- 
thritis  (21-23),  including  the  direct  demonstration  of T  lymphocytes  in  the 
synovium of rats  with  CIA (24).  However, the  data from our passive transfer 
experiments suggest that, in AA, the destructive capacity of the cellular immune 
responses is substantially greater than in CIA. 
The conclusion that AA and CIA have different pathogenetic mechanisms is 
consistent  with  the  findings  of several  investigators,  who  have  reported  that 
significant levels ofanti-CII do not develop in AA rats (25-27), that arthritogenic 
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AA and CIA are not susceptible to cross-tolerization  (21, 25, 26). While there 
have also been reports of suppression of AA by administration  of CII (27,  28), 
these  reports  are  not  necessarily  in  conflict  with  our  findings  or  conclusions, 
since the mechanism of this suppression may not be antigen-specific. 
We have found only one other report of a positive interaction between humoral 
and  cellular  mechanisms  in  the  passive  transfer  of experimental  autoimmune 
disease  (29).  However,  in  complex  human  diseases,  it  is  likely  that  several 
indepenent events contribute to disease expression. Synergistic mechanisms such 
as we have demonstrated may operate in human rheumatoid arthritis,  in which 
accumulations of both intrasynovial immune complexes and inflammatory mono- 
nuclear cells are readily observed (30).  It is conceivable that the effect of anti- 
CII in our synergy model is not specific; rather,  the critical factor may be a high 
density of intrasynovial immunoglobulin of the proper isotype, which, independ- 
ently of its antigenic specificity, provides a matrix of in situ immune complexes 
that  promotes  cell-mediated  inflammation  and  destruction,  analogous  to  the 
situation  in  rheumatoid  arthritis  (30,  31).  Further  experimentation  with  this 
model should produce better understanding of its mechanisms and its application 
to human disease. 
Summary 
Adjuvant arthritis  (AA) in rats is susceptible to cell-mediated passive transfer. 
Collagen-induced  arthritis  (CIA)  in  rats  is  susceptible to passive transfer  with 
antibody to type II collagen. We report here the development of strikingly severe 
arthritis  in  Lewis  rats  as  the  result  of synergy  between passively transferred 
antibody to type II collagen from rats with CIA and concanavalin  A  (Con A)- 
stimulated  lymph  node  or  spleen  cells  from  syngeneic  rats  with  AA.  Similar 
synergy was seen in rats with AA given anticollagen antibody, in rats with CIA 
given Con  A-stimulated  adjuvant  spleen  cells, and  in  rats actively immunized 
with CII and complete Freund's adjuvant. The synergistic process caused a very 
severe polyarthritis,  characterized  by marked  swelling and erythema in all  the 
joints of the distal extremities, with histologic and radiographic evidence of early, 
extensive erosion of articular  cartilage.  Synergy was apparent  if the  lymphoid 
cells from AA rats were given up to 1 mo after a single injection of anticollagen 
antibody.  No synergy was seen when  normal  rat  immunoglobulin  or antioval- 
bumin antibody was substituted for anticollagen antibody, when Con A-stimu- 
lated lymphoid cells from normal rats or donors with CIA were used, or when 
Con A-stimulated  AA lymphoid cells were irradiated  before transfer.  Synergy 
between separate immune effector mechanisms may represent a general phenom- 
enon in the pathogenesis of inflammatory joint disease. 
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